NPI: 1245217751 · JERSEY CITY, NJ 07307 · 207R00000X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 7,206 | $212K |
| 2019 | 4,851 | $142K |
| 2020 | 3,228 | $79K |
| 2021 | 3,893 | $96K |
| 2022 | 4,535 | $94K |
| 2023 | 5,907 | $105K |
| 2024 | 3,667 | $70K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | 9,287 | 7,840 | $346K | |
| 96401 | 8,916 | 5,450 | $342K | |
| 99204 | 409 | 392 | $34K | |
| 96372 | 2,363 | 1,397 | $21K | |
| 20605 | 446 | 422 | $11K | |
| 99244 | 75 | 74 | $8K | |
| J9250 | Methotrexate sodium inj | 8,386 | 5,035 | $7K |
| 73120 | 368 | 185 | $7K | |
| 99245 | 47 | 47 | $7K | |
| 73620 | 173 | 87 | $3K | |
| 73565 | 138 | 138 | $3K | |
| J0702 | Betamethasone acet&sod phosp | 591 | 549 | $3K |
| 73030 | 126 | 63 | $2K | |
| 20610 | 53 | 51 | $2K | |
| J9255 | Inj, methotrexate (accord) | 739 | 448 | $1K |
| J9260 | Inj methotrexate sodium 50mg | 38 | 35 | $15.22 |
| J0135 | Adalimumab injection | 1,132 | 632 | $2.00 |